Connect with us

AI Research

Research has shown that artificial intelligence (AI) coding aids do not increase the productivity of..

Published

on


METR “Average 19% Increase in Working Hours” Depends On Productivity Expectations

AI coding tools are rather ‘inefficient’ for skilled developers [Picture = ChatGPT]

Research has shown that artificial intelligence (AI) coding aids do not increase the productivity of all developers. In particular, it is pointed out that there may be an adverse effect of increasing working time for skilled developers.

The AI safety non-profit research institute METR said a recent randomized controlled trial found that AI-based coding tools such as GitHub Copilot and Cursor Pro reduce the speed of career developers by 19% on average. The experiment involved 16 skilled developers who have contributed to open-source projects, and a total of 246 real-world tasks were targeted for the experiment.

Participants predicted that using AI would reduce working time by an average of 24%. However, the actual measured time was the opposite. The group using AI, on average, took nearly 19% more time. “It goes against the general belief that the use of AI tools speeds up,” the METR said of the results.

The METR pointed to the increase in prompt writing and response waiting times, the limitations of AI’s contextual understanding in complex large-scale codebases, and the lack of consistency in AI-based coding assistance systems as reasons for slowing the use of AI. In fact, it was found that developers spent more time writing prompts and reviewing results for writing AI than coding. In the case of experienced developers, it may have taken more time to modify the code proposed by AI without writing it as it is, as they are familiar with the code they enjoy using.

Other previous studies have shown that AI coding tools speed up by 21% on average and up to 56%.

However, the researchers explained, “It is only an observation at the present time,” adding, “It means that not all AI coding tools increase productivity.”



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

AI Research

Lila Sciences raises $235 million to expand AI-driven research platform | Pharmaceutical | The Pharmaletter

Published

on


Lila Sciences has secured $235 million in series A financing, co-led by Braidwell and Collective Global, at a valuation of about $1.23 billion. The Massachusetts-based company, founded by Flagship Pioneering in 2023, is building an artificial intelligence platform designed to automate and accelerate the scientific method across multiple disciplines.

The latest financing follows a $200-million seed round in March and will be used to hire staff and open new sites in Boston, San Francisco and London. These locations will house the company’s so-called AI Science Factories, facilities that integrate AI, robotics and laboratory systems to design and run experiments at scale. Lila says these factories have already conducted hundreds of thousands of studies across life science, chemistry and materials science.

Building autonomous science at scale

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now

  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Source link

Continue Reading

AI Research

Gachon University establishes AI·Computing Research Institute – 조선일보

Published

on



Gachon University establishes AI·Computing Research Institute  조선일보



Source link

Continue Reading

AI Research

Tech war: Tencent pushes adoption of Chinese AI chips as mainland cuts reliance on Nvidia

Published

on

By


The Shenzhen-based tech conglomerate’s cloud computing unit, Tencent Cloud, said it was supporting “mainstream domestic chips” in its AI computing infrastructure, without naming any Chinese integrated circuit brand.

Tencent has “fully adapted to mainstream domestic chips” and “participates in the open-source community”, Tencent Cloud president Qiu Yuepeng said at the company’s annual Global Digital Ecosystem Summit on Tuesday.

It is a commitment that reflects growing efforts in the country’s semiconductor industry and AI sector to push forward Beijing’s tech self-sufficiency agenda amid US export restrictions on China and rising geopolitical tensions.
Tencent Cloud unveils support for Chinese-designed AI chips at the company’s annual Global Digital Ecosystem Summit. Photo: Weibo



Source link

Continue Reading

Trending